Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance.

Palmer, D. C.,Guittard, G. C.,Franco, Z.,Crompton, J. G.,Eil, R. L.,Patel, S. J.,Ji, Y.,Van Panhuys, N.,Klebanoff, C. A.,Sukumar, M.,Clever, D.,Chichura, A.,Roychoudhu...; J. Exp. Med.. 2015 Nov 04.

Type I cytokines synergize with oncogene inhibition to induce tumor growth arrest.

Acquavella, N.,Clever, D.,Yu, Z.,Roelke-Parker, M.,Palmer, D. C.,Xi, L.,Pflicke, H.,Ji, Y.,Gros, A.,Hanada, K.,Goldlust, I. S.,Mehta, G. U.,Klebanoff, C. A.,Crompton, ...; Cancer Immunol Res. 2014 Nov 02.

Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics.

Crompton, J. G.,Sukumar, M.,Roychoudhuri, R.,Clever, D.,Gros, A.,Eil, R. L.,Tran, E.,Hanada, K.,Yu, Z.,Palmer, D. C.,Kerkar, S. P.,Michalek, R. D.,Upham, T.,Leonardi, ...; Cancer Res.. 2014 Nov 30.